These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23085593)

  • 1. Zinc(II) complexes with dithiocarbamato derivatives: structural characterisation and biological assays on cancerous cell lines.
    Nagy EM; Sitran S; Montopoli M; Favaro M; Marchiò L; Caparrotta L; Fregona D
    J Inorg Biochem; 2012 Dec; 117():131-9. PubMed ID: 23085593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promising anticancer mono- and dinuclear ruthenium(III) dithiocarbamato complexes: systematic solution studies.
    Nagy EM; Nardon C; Giovagnini L; Marchiò L; Trevisan A; Fregona D
    Dalton Trans; 2011 Nov; 40(44):11885-95. PubMed ID: 21971872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Midas touch in cancer chemotherapy: from platinum- to gold-dithiocarbamato complexes.
    Ronconi L; Fregona D
    Dalton Trans; 2009 Dec; (48):10670-80. PubMed ID: 20023894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical and biological profiles of novel copper(II) complexes containing S-donor ligands for the treatment of cancer.
    Giovagnini L; Sitran S; Montopoli M; Caparrotta L; Corsini M; Rosani C; Zanello P; Dou QP; Fregona D
    Inorg Chem; 2008 Jul; 47(14):6336-43. PubMed ID: 18572881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
    Ronconi L; Giovagnini L; Marzano C; Bettìo F; Graziani R; Pilloni G; Fregona D
    Inorg Chem; 2005 Mar; 44(6):1867-81. PubMed ID: 15762713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of gold(III)-dithiocarbamato peptidomimetics for the targeted anticancer chemotherapy.
    Kouodom MN; Boscutti G; Celegato M; Crisma M; Sitran S; Aldinucci D; Formaggio F; Ronconi L; Fregona D
    J Inorg Biochem; 2012 Dec; 117():248-60. PubMed ID: 22877925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes.
    Giovagnini L; Ronconi L; Aldinucci D; Lorenzon D; Sitran S; Fregona D
    J Med Chem; 2005 Mar; 48(5):1588-95. PubMed ID: 15743200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ru(III)-based compounds with sulfur donor ligands: synthesis, characterization, electrochemical behaviour and anticancer activity.
    Giovagnini L; Sitran S; Castagliuolo I; Brun P; Corsini M; Zanello P; Zoleo A; Maniero A; Biondi B; Fregona D
    Dalton Trans; 2008 Dec; (47):6699-708. PubMed ID: 19153618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands.
    Sanghvi CD; Olsen PM; Elix C; Peng SB; Wang D; Chen ZG; Shin DM; Hardcastle KI; MacBeth CE; Eichler JF
    J Inorg Biochem; 2013 Nov; 128():68-76. PubMed ID: 23948576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies.
    Pellei M; Papini G; Trasatti A; Giorgetti M; Tonelli D; Minicucci M; Marzano C; Gandin V; Aquilanti G; Dolmella A; Santini C
    Dalton Trans; 2011 Oct; 40(38):9877-88. PubMed ID: 21709917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-oxidant, in vitro, in vivo anti-inflammatory activity and antiproliferative activity of mefenamic acid and its metal complexes with manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II).
    Kovala-Demertzi D; Hadjipavlou-Litina D; Staninska M; Primikiri A; Kotoglou C; Demertzis MA
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):742-52. PubMed ID: 18720191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ruthenium(II/III)-based compounds with encouraging antiproliferative activity against non-small-cell lung cancer.
    Nagy EM; Pettenuzzo A; Boscutti G; Marchiò L; Dalla Via L; Fregona D
    Chemistry; 2012 Nov; 18(45):14464-72. PubMed ID: 23012112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-classical anticancer agents: synthesis and biological evaluation of zinc(II) heteroleptic complexes.
    Liguori PF; Valentini A; Palma M; Bellusci A; Bernardini S; Ghedini M; Panno ML; Pettinari C; Marchetti F; Crispini A; Pucci D
    Dalton Trans; 2010 May; 39(17):4205-12. PubMed ID: 20390185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic activity, X-ray crystal structures and spectroscopic characterization of cobalt(II), copper(II) and zinc(II) coordination compounds with 2-substituted benzimidazoles.
    Sánchez-Guadarrama O; López-Sandoval H; Sánchez-Bartéz F; Gracia-Mora I; Höpfl H; Barba-Behrens N
    J Inorg Biochem; 2009 Sep; 103(9):1204-13. PubMed ID: 19628280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands.
    Porchia M; Benetollo F; Refosco F; Tisato F; Marzano C; Gandin V
    J Inorg Biochem; 2009 Dec; 103(12):1644-51. PubMed ID: 19822369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward the selective delivery of chemotherapeutics into tumor cells by targeting peptide transporters: tailored gold-based anticancer peptidomimetics.
    Kouodom MN; Ronconi L; Celegato M; Nardon C; Marchiò L; Dou QP; Aldinucci D; Formaggio F; Fregona D
    J Med Chem; 2012 Mar; 55(5):2212-26. PubMed ID: 22309237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of apoptosis and cell selectivity of zinc dithiocarbamates functionalized with hydroxyethyl substituents.
    Tan YS; Ooi KK; Ang KP; Akim AM; Cheah YK; Halim SN; Seng HL; Tiekink ER
    J Inorg Biochem; 2015 Sep; 150():48-62. PubMed ID: 26086852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cu
    Pettenuzzo N; Brustolin L; Coltri E; Gambalunga A; Chiara F; Trevisan A; Biondi B; Nardon C; Fregona D
    ChemMedChem; 2019 Jun; 14(12):1162-1172. PubMed ID: 31091012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A series of oxyimine-based macrocyclic dinuclear zinc(II) complexes enhances phosphate ester hydrolysis, DNA binding, DNA hydrolysis, and lactate dehydrogenase inhibition and induces apoptosis.
    Anbu S; Kamalraj S; Varghese B; Muthumary J; Kandaswamy M
    Inorg Chem; 2012 May; 51(10):5580-92. PubMed ID: 22553985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization, DNA binding and cleavage, BSA interaction and anticancer activity of dinuclear zinc complexes.
    Gao CY; Qiao X; Ma ZY; Wang ZG; Lu J; Tian JL; Xu JY; Yan SP
    Dalton Trans; 2012 Oct; 41(39):12220-32. PubMed ID: 22930131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.